Cite
MLA Citation
Christopher Wynne et al.. “A randomized, adaptive design, double-blind, 3-arm, parallel study assessing the pharmacokinetics and safety of AVT02, a high-concentration (100 mg/mL) Adalimumab biosimilar, in healthy adult subjects (ALVOPAD FIRST).” Expert opinion on investigational drugs, vol. 31, 2022, pp. 965–976. http://access.bl.uk/ark:/81055/vdc_100167016206.0x00002a